Samsung Medical Center-ko ikertzaileekin lankidetzan egindako argitalpenak (1)

2021

  1. Adjunctive Volasertib in Patients with Acute Myeloid Leukemia not Eligible for Standard Induction Therapy: A Randomized, Phase 3 Trial

    HemaSphere, Vol. 5, Núm. 8, pp. E617